This project is part of a consortium initiative, the Maternal Immunization Readiness Network in Africa and Asia (MIRNA). MIRNA aims to generate the evidence necessary for the introduction of maternal vaccines against Respiratory Syncytial Virus and Group B Streptococcus. These pathogens are causes of significant morbidity and mortality associated with preterm labor, stillbirth, neonatal sepsis, pneumonia, and other respiratory illnesses.

MIRNA aims to estimate the burden associated with these illnesses and characterize different levels of care, policy, and preparedness requirements for introduction of maternal vaccines against respiratory syncytial virus and Group B Streptococcus pathogens in Ethiopia. MIRNA intends to harmonize Maternal Immunization readiness activities across Asia and Africa by developing a shared approach to assessing maternal immunization delivery readiness across delivery pathways.

Maternal Immunization is the practice of vaccinating pregnant women to induce immunity and protect the fetus and infant through transplacental transfer of immunity. It is a promising approach to reducing maternal and infant mortality and morbidity.